Advisor - Analytical Development Gene Therapy
Eli Lilly and Company
Summary
The Advisor Analytical Development will be responsible for testing, development and establishment of new methods for characterization of AAV, gene editing and novel gene therapy technologies used in novel targets. This position will manage scientists, interact with other departments and lead on-going and new pipeline project. This person will contribute the overall R&D strategy and planning. The ideal candidate will have a track record of molecular biology, long read NGS, virology, developing assays, ability to coordinate efforts across departments.
Job description
Responsibilities
- Lead, grow and manage scientists and research associates experienced gene therapy in the DNA Molecular Biology Group
- Perform testing of material used for research
- Design, implement and troubleshoot assay and techniques
- Establish new technologies and develop new assays to assess gene therapy products quality
- Author and review documents including development reports, SOPs, assay transfer protocols/reports, scientific journal publications
- Provide project leadership to gene therapy and/or gene editing programs
- Advance scientific understanding of gene therapy and gene editing products by applying innovative analytics research techniques and leading studies that aim to deepen product understanding
Basic Requirements
- PhD with specialization in Virology, Biochemistry, Biology, Molecular Biology, or related scientific field
- 2+ years of industry experience
Additional Skills/Preferences
- Direct experience and good understanding in gene therapy or gene editing technologies
- Hand on experience in NGS / PacBio
- Experience in Virology, Cell Biology, Genetics, Molecular Biology, Biochemistry, Systems Biology, Immunology, or related scientific field
- Experience in hiring and managing a team
- Demonstrated proficiency and ability to deliver goals
- Experience in timeline management and resource planning
- Understanding of quality control processes
- Hands-on experience with pioneering analytical instruments
- Excellent organizational, documentation, and communication skills; adaptive learning, critical thinking, and the ability to work well in a team
Requirements
- PhD with specialization in Virology, Biochemistry, Biology, Molecular Biology, or related scientific field
- 2+ years of industry experience
- Direct experience and good understanding in gene therapy or gene editing technologies
- Hands-on experience in NGS / PacBio
- Experience in Virology, Cell Biology, Genetics, Molecular Biology, Biochemistry, Systems Biology, Immunology, or related scientific field
- Experience in hiring and managing a team
- Demonstrated proficiency and ability to deliver goals
- Experience in timeline management and resource planning
- Understanding of quality control processes
- Hands-on experience with pioneering analytical instruments
- Excellent organizational, documentation, and communication skills
- Adaptive learning, critical thinking, and ability to work well in a team
Benefits
- 401(k)
- Pension
- Vacation benefits
- Medical, Dental & Vision
- Prescription drug benefits
- Flexible spending accounts
- Life insurance
- Death benefits
- Employee assistance program
- Fitness benefits
- Company bonus
Company overview
Eli Lilly and Company, commonly known as Lilly, is a leading American multinational pharmaceutical corporation headquartered in Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly, the company has grown into one of the world's most valuable pharmaceutical enterprises, with operations in approximately 125 countries. Lilly specializes in developing and manufacturing innovative medicines across multiple therapeutic areas, including diabetes, oncology, neuroscience, immunology, and cardiometabolic diseases. The company is renowned for its groundbreaking work in insulin production, having been the first to mass-produce insulin and later developing the first commercially available insulin product in the U.S. Lilly's current portfolio includes blockbuster medications such as Mounjaro and Zepbound (tirzepatide) for diabetes and obesity, Trulicity (dulaglutide) for type 2 diabetes, Verzenio (abemaciclib) for breast cancer, and Taltz (ixekizumab) for autoimmune conditions. With approximately 47,000 employees worldwide, Lilly maintains a strong commitment to research and development, investing heavily in scientific innovation to address some of the world's most significant health challenges. The company operates with a mission to make life better for people around the world through the discovery and delivery of innovative medicines.